Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Proniras Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT06538558
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
News
No news found